180 related articles for article (PubMed ID: 12651759)
1. Are tablets a practical source of protein substitute in phenylketonuria?
MacDonald A; Ferguson C; Rylance G; Morris AA; Asplin D; Hall SK; Booth IW
Arch Dis Child; 2003 Apr; 88(4):327-9. PubMed ID: 12651759
[TBL] [Abstract][Full Text] [Related]
2. A new, low-volume protein substitute for teenagers and adults with phenylketonuria.
MacDonald A; Lilburn M; Cochrane B; Davies P; Daly A; Asplin D; Hall SK; Cousins A; Chakrapani A; Robinson P; Lee P
J Inherit Metab Dis; 2004; 27(2):127-35. PubMed ID: 15159643
[TBL] [Abstract][Full Text] [Related]
3. 'Ready to drink' protein substitute is easier is for people with phenylketonuria.
MacDonald A; Lilburn M; Davies P; Evans S; Daly A; Hall SK; Hendriksz C; Chakrapani A; Lee P
J Inherit Metab Dis; 2006 Aug; 29(4):526-31. PubMed ID: 16736099
[TBL] [Abstract][Full Text] [Related]
4. Long-term compliance with a novel vitamin and mineral supplement in older people with PKU.
MacDonald A; Lee P; Davies P; Daly A; Lilburn M; Gokmen Ozel H; Preece MA; Hendriksz C; Chakrapani A
J Inherit Metab Dis; 2008 Dec; 31(6):718-23. PubMed ID: 18941921
[TBL] [Abstract][Full Text] [Related]
5. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
Daly A; Evans S; Chahal S; Santra S; MacDonald A
J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.
Daly A; Evans S; Chahal S; Santra S; Pinto A; Gingell C; Rocha JC; van Spronsen F; Jackson R; MacDonald A
Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823411
[No Abstract] [Full Text] [Related]
7. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
[TBL] [Abstract][Full Text] [Related]
8. An Observational Study Evaluating the Introduction of a Prolonged-Release Protein Substitute to the Dietary Management of Children with Phenylketonuria.
MacDonald A; Ashmore C; Daly A; Pinto A; Evans S
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32899129
[TBL] [Abstract][Full Text] [Related]
9. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
[TBL] [Abstract][Full Text] [Related]
10. Protein substitute dosage in PKU: how much do young patients need?
MacDonald A; Chakrapani A; Hendriksz C; Daly A; Davies P; Asplin D; Hall K; Booth IW
Arch Dis Child; 2006 Jul; 91(7):588-93. PubMed ID: 16547085
[TBL] [Abstract][Full Text] [Related]
11. Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids.
van Calcar SC; MacLeod EL; Gleason ST; Etzel MR; Clayton MK; Wolff JA; Ney DM
Am J Clin Nutr; 2009 Apr; 89(4):1068-77. PubMed ID: 19244369
[TBL] [Abstract][Full Text] [Related]
12. Does a lower carbohydrate protein substitute impact on blood phenylalanine control, growth and appetite in children with PKU?
Gokmen-Ozel H; Ferguson C; Evans S; Daly A; MacDonald A
Mol Genet Metab; 2011; 104 Suppl():S64-7. PubMed ID: 21978770
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of 'ready-to-drink' protein substitute in phenylketonuria.
Gokmen-Ozel H; MacDonald A; Daly A; Hall K; Ryder L; Chakrapani A
J Hum Nutr Diet; 2009 Oct; 22(5):422-7. PubMed ID: 19743980
[TBL] [Abstract][Full Text] [Related]
14. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
[TBL] [Abstract][Full Text] [Related]
15. Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria.
Daly A; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; MacDonald A
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823853
[TBL] [Abstract][Full Text] [Related]
16. Acceptability of a new modular protein substitute for the dietary treatment of phenylketonuria.
Rohr FJ; Munier AW; Levy HL
J Inherit Metab Dis; 2001 Nov; 24(6):623-30. PubMed ID: 11768582
[TBL] [Abstract][Full Text] [Related]
17. Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes.
Daly A; Högler W; Crabtree N; Shaw N; Evans S; Pinto A; Jackson R; Strauss BJ; Wilcox G; Rocha JC; Ashmore C; MacDonald A
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33923714
[TBL] [Abstract][Full Text] [Related]
18. Protein substitute for children and adults with phenylketonuria.
Rutherford P; Poustie VJ
Cochrane Database Syst Rev; 2005 Oct; (4):CD004731. PubMed ID: 16235378
[TBL] [Abstract][Full Text] [Related]
19. Phenylketonuria: tyrosine supplementation in phenylalanine-restricted diets.
van Spronsen FJ; van Rijn M; Bekhof J; Koch R; Smit PG
Am J Clin Nutr; 2001 Feb; 73(2):153-7. PubMed ID: 11157309
[TBL] [Abstract][Full Text] [Related]
20. Protein Substitutes in PKU; Their Historical Evolution.
Daly A; Evans S; Pinto A; Ashmore C; MacDonald A
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33540516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
